News

Aalto-born Surgify raises a €1.0M seed investment round

The Surgify Safety burr prevents the nerve and blood vessel injuries that are typically caused by other surgical drills.

A surgeon using the Surgify Safety Burr in a simulated surgery. Photo: Surgify

The technology can be easily used with existing surgical drills, and its usage does not require any additional training for the surgeon or the staff. The patent pending safety mechanism prevents the drill from damaging vital tissues, such as nerves or blood vessels. Besides neurosurgical applications, the innovation can be used in the future also in spine surgery and in the fields of orthopedics and dentistry.

“The technology has raised great interest amongst hospitals and surgeons globally. For example, we recently visited Harvard University’s teaching hospitals in Boston, and the reception was enthusiastic”, tells Visa Sippola, the CEO of Surgify.

The technology has been initially developed in cooperation between Aalto University and Department of Neurosurgery at Helsinki University Hospital. The company aims to bring the Safety Burr technology to the market in 2019. The company thereafter plans to initiate sales in the Nordic Countries, after which it will expand the business to global markets. In addition to the easy adoption process of the technology, the considerable reductions in costs and surgical complications are expected to positively affect the demand for the solution.

“Our core mission is to make bone surgery safer, as we believe that our technology has the potential to save lives in the future. The fact that we also bring clear cost savings to surgery will be of help in carrying out that mission – for example the complications caused by the current surgical drills cost over 4 billion euros each year globally”, Sippola explains.

The investors joining the startup’s second round of financing include a Finnish venture capital firm Butterfly Ventures, as well as Cascara Ventures from Belgium, Merkatura AB (Andreas Bunge) from Sweden and FRIIH GmBH (Dr. Michael Friebe) from Germany. The funding will be used to finalize the neurosurgical burr and to apply for a sales approval in Europe.

Read also: Safer bone surgery thanks to a technique patented at Aalto

Contact:

Visa Sippola
CEO, Surgify Medical
+358 50 353 1232
visa.sippola@surgifymedical.com

  • Updated:
  • Published:
Share
URL copied!

Read more news

Learning Centre graphics
Research & Art, Studies Published:

The proxy server for remote access to e-resources is changing

If you have problems using e-resources, try accessing the e-resource using VPN connection.
Ikääntyneitä asukkaita katsomassa kasvatuslaatikoita kirjaston edessä
Cooperation, Research & Art Published:

A sustainable city is also age-friendly

Cities must involve older adults more strongly in the planning of the urban environment.
Aalto Startup Center x A Grid Demo Day 2026
Campus, Cooperation Published:

Join us for Demo Day 2026 - March 4 at A Grid

On March 4th, A Grid is the place to be because Aalto Startup Center x A Grid Demo Day will be taking place.
Interns discussing their scientific poster
Research & Art Published:

Renate Zhang’s journey in optimising the cost of creation

During the research program at Aalto University, Renate Zhang developed a cost-saving method that inspired her to pursue a doctoral degree.